TB4 10mg (10 vials/Kit) ‎: Full-Length Thymosin Beta-4 for Regenerative Research

Thymosin Beta-4 ($\text{TB4}$) is a naturally occurring, highly conserved 43-amino-acid peptide ($\text{Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES}$) that functions as the primary G-actin sequestering molecule in eukaryotic cells. By maintaining the intracellular balance between monomeric G-actin and polymeric F-actin, TB4 governs cytoskeleton reorganization, cell motility, wound healing kinetics, and microvascular sprouting. Sourcing TB4 10mg (10 vials/Kit) provides biotechnology institutions, academic laboratories, and regenerative medicine researchers with a full-length, high-purity analytical reagent engineered to investigate cell migration, focal adhesion dynamics, cardiovascular repair, and tissue remodeling in preclinical models.

In physiological systems, TB4 is present in high concentrations in blood platelets, wound fluid, and damaged tissues. When cellular injury occurs, TB4 is released locally to coordinate multiple phases of biological repair. Unlike smaller synthetic fragments that isolate specific actin-binding motifs, full-length TB4 provides the complete native protein structure, facilitating multi-pathway interactions including the upregulation of vascular endothelial growth factor ($\text{VEGF}$), activation of progenitor cell differentiation, and modulation of pro-inflammatory nuclear factor kappa B ($\text{NF-}\kappa\text{B}$) cascades.

Maintaining batch uniformity and chemical stability is critical for quantitative cellular and physiological bioassays. The TB4 10mg (10 vials/Kit) configuration supplies a total yield of 100mg active peptide material distributed across ten individual 10mg USP Type I borosilicate glass vials. Lyophilized under sterile vacuum conditions, each vial contains a uniform, highly stable powder cake. This multi-vial kit format enables laboratory personnel to reconstitute only the active working volume required for immediate experimental runs, keeping remaining kit stock preserved in sub-zero stasis to prevent thermal degradation caused by repeated freeze-thaw cycles.

Actin Dynamics, Angiogenesis, and Technical Profile of TB4

The primary scientific value of TB4 10mg (10 vials/Kit) stems from its central regulatory role in cell motility and tissue architectural repair:

• G-Actin Sequestering & Cytoskeleton Dynamics: Binds 1:1 with monomeric G-actin to maintain an intracellular actin pool, enabling rapid actin filament assembly required for lamellipodia formation and cell locomotion.

• Endothelial Migration & Microvascular Sprouting: Stimulates endothelial cell migration and capillary tube formation, driving neovascularization in ischemic tissue models.

• Progenitor Cell Mobilization: Promotes the survival, differentiation, and migration of cardiac, dermal, and neural progenitor cells to sites of tissue damage.

• Anti-Fibrotic & Anti-Inflammatory Modulation: Suppresses pro-inflammatory cytokines ($\text{TNF-}\alpha$, $\text{IL-1}\beta$) and decreases collagen deposition in scar-forming tissues, promoting organized parenchymal regeneration.

• Full-Length Native Structure: Contains the entire 43-amino-acid sequence with N-terminal acetylation, delivering the full biological repertoire of native Thymosin Beta-4.

• Ultra-High Chemical Purity ($\ge$99.0%): Manufactured via automated Solid-Phase Peptide Synthesis (SPPS) and purified using preparative High-Performance Liquid Chromatography (HPLC) to guarantee freedom from sequence truncation artifacts.

Reconstitution Guidelines, Laboratory Storage Standards, and Quality Protocols

Achieving reproducible, publication-grade results when working with TB4 10mg (10 vials/Kit) requires strict adherence to standardized laboratory preparation and climate-controlled storage protocols.

Perform all reconstitution procedures inside a certified Class II Biosafety Cabinet:

1. Temperature Equilibration: Allow the frozen TB4 10mg (10 vials/Kit) vial to adjust to ambient room temperature prior to solvent introduction to eliminate moisture condensation inside the glass container.

2. Septum Sanitization: Remove the protective plastic flip-cap and thoroughly wipe the synthetic rubber stopper with a fresh 70% isopropyl alcohol pad. Allow the surface to dry completely.

3. Slow Diluent Addition: Using a sterile syringe equipped with a fine-gauge needle, draw the required volume of Bacteriostatic Water (0.9% benzyl alcohol), Sterile Normal Saline (0.9% NaCl), or Phosphate-Buffered Saline (PBS). Direct the stream against the inner glass wall so it trickles gently over the lyophilized cake.

4. Gentle Hydration: Allow the diluent to fully hydrate the powder cake for 2 to 3 minutes. Gently roll the vial between your palms or swirl in smooth circular motions until clear. Never vortex or shake vigorously, as high-shear agitation can shear peptide bonds and induce protein foaming.

5. Micro-Aliquot Strategy: For multi-week testing protocols, divide reconstituted liquid into sterile, single-use microcentrifuge tubes under aseptic conditions to prevent atmospheric oxidation and eliminate repeated freeze-thaw cycles.

Batch Quality Documentation & Traceability: Every production lot of TB4 10mg (10 vials/Kit) undergoes third-party analytical testing. High-Performance Liquid Chromatography (HPLC) chromatograms confirm component purity exceeding 99.0%, while Electrospray Ionization Mass Spectrometry (ESI-MS) confirms precise theoretical molecular mass. Each shipment includes a batch-specific Certificate of Analysis (COA) documenting chemical purity, residual solvent analysis, heavy metal screens, and bacterial endotoxin levels (<0.05 EU/mg) to satisfy institutional compliance requirements.

Strict Regulatory & Research Compliance Statement: TB4 10mg (10 vials/Kit) is produced, packaged, and distributed exclusively for in vitro laboratory research, academic experimentation, chemical synthesis, and preclinical research. TB4 10mg (10 vials/Kit) is strictly not intended, formulated, or approved for human or animal consumption, therapeutic medical treatment, clinical diagnostic work, or cosmetic applications. All handling must be conducted by certified research personnel operating within equipped laboratory facilities in compliance with OSHA workplace safety regulations and institutional biosafety protocols.